JOHNSON & JOHNSON Share Price & Technical Analysis
JNJ · $253.9 (-1.52%)
Healthcare / Drug Manufacturers - General
$253.9
-1.52%
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases…
Price chart
Seasonality
Jul has 4 positive and 1 negative years (last 5 years shown)
0% return in Jul, 6% avg return in past 3 year Jul month.
23% return in 2026, 7% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 10% | 9% | -2% | -6% | -2% | 14% | 0% | – | – | – | – | – | 23% |
| 25 | 5% | 9% | 0% | -3% | 0% | -1% | 8% | 7% | 4% | 2% | 9% | 0% | 40% |
| 24 | 1% | 2% | -2% | -8% | -1% | -1% | 8% | 5% | -2% | -2% | -3% | -7% | -10% |
| 23 | -7% | -6% | 1% | 6% | -5% | 7% | 2% | -3% | -3% | -5% | 4% | 0% | -9% |
| 22 | 1% | -4% | 9% | 2% | -1% | -1% | -2% | -7% | 1% | 6% | 2% | -1% | 5% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$598.00B
P/E ratio
28.82
52W high
$269.4
52W low
$154.8
Volume
87,70,522
Related stocks in Healthcare
Eli Lilly And Company
₹1,157
Mckesson Corporation
₹796.4
Idexx Laboratories, Inc.
₹557.0
Frequently asked questions
- What is JOHNSON & JOHNSON share price today?
- JOHNSON & JOHNSON (JNJ) last traded around $253.9 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does JNJ have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for JNJ. Download the app for real-time alerts.
- How can I analyze JOHNSON & JOHNSON stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.